BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34558234)

  • 1. Nanotechnology for Targeted Detection and Removal of Bacteria: Opportunities and Challenges.
    Hajipour MJ; Saei AA; Walker ED; Conley B; Omidi Y; Lee KB; Mahmoudi M
    Adv Sci (Weinh); 2021 Nov; 8(21):e2100556. PubMed ID: 34558234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in nanotechnology for eradicating bacterial biofilm.
    Sahli C; Moya SE; Lomas JS; Gravier-Pelletier C; Briandet R; Hémadi M
    Theranostics; 2022; 12(5):2383-2405. PubMed ID: 35265216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial in controlling biofilms and virulence of microbial pathogens.
    Tungare K; Gupta J; Bhori M; Garse S; Kadam A; Jha P; Jobby R; Amanullah M; Vijayakumar S
    Microb Pathog; 2024 Jul; 192():106722. PubMed ID: 38815775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of biofilm-associated infections by signaling molecules and nanoparticles.
    Holban AM; Gestal MC; Grumezescu AM
    Int J Pharm; 2016 Aug; 510(2):409-18. PubMed ID: 26945736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control.
    Liu Y; Shi L; Su L; van der Mei HC; Jutte PC; Ren Y; Busscher HJ
    Chem Soc Rev; 2019 Jan; 48(2):428-446. PubMed ID: 30601473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics.
    Diab R; Khameneh B; Joubert O; Duval R
    Curr Pharm Des; 2015; 21(28):4095-105. PubMed ID: 26420233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
    Alabresm A; Chandler SL; Benicewicz BC; Decho AW
    Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
    Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
    Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticulate drug-delivery systems for fighting microbial biofilms: from bench to bedside.
    Pircalabioru GG; Chifiriuc MC
    Future Microbiol; 2020 May; 15():679-698. PubMed ID: 32495694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials as Promising Alternative in the Infection Treatment.
    Vallet-Regí M; González B; Izquierdo-Barba I
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
    Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
    Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterials for the Treatment of Bacterial Biofilms.
    Wang LS; Gupta A; Rotello VM
    ACS Infect Dis; 2016 Jan; 2(1):3-4. PubMed ID: 27622944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology Approaches for Rapid Detection and Theranostics of Antimicrobial Resistant Bacterial Infections.
    Saxena S; Punjabi K; Ahamad N; Singh S; Bendale P; Banerjee R
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2232-2257. PubMed ID: 35546526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.